Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

Press releases published on September 22, 2026

9 hours ago

Cynet Announces Version 5.0 of its Platform, Unveiling New Cross-Site Dashboard and Enhanced SIEM Capabilities to Maximize Speed, Scale, and Interoperability

Indeterminate GlobeNewswire

10 hours ago

Bevimi Announces Strategic Partnership with RESOLV Proving Ground to Support Special Operations Veteran Brain Health

Indeterminate GlobeNewswire

10 hours ago

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

Indeterminate GlobeNewswire

10 hours ago

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

10 hours ago

Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System

Indeterminate GlobeNewswire

10 hours ago

OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health

Indeterminate GlobeNewswire

10 hours ago

Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD

Indeterminate GlobeNewswire

10 hours ago

Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

Indeterminate GlobeNewswire

10 hours ago

SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes

Indeterminate GlobeNewswire

10 hours ago

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Indeterminate GlobeNewswire

10 hours ago

Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback

Indeterminate GlobeNewswire

10 hours ago

Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Indeterminate GlobeNewswire

10 hours ago

Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib

Indeterminate GlobeNewswire

10 hours ago

Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Indeterminate GlobeNewswire

10 hours ago

Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

Indeterminate GlobeNewswire

10 hours ago

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

10 hours ago

SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner

Indeterminate GlobeNewswire

10 hours ago

IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review

Indeterminate GlobeNewswire

10 hours ago

Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

10 hours ago

Clene to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire